Evidence mapPaperPMID 41214287Full record

ReviewNature reviews. Gastroenterology & hepatology2026

Mechanistic insights into the liver-brain axis during chronic liver disease.

Matthew Siddle, Rocío Gallego Durán, Deepika Goel, Benjamin J Renquist, Marie K Holt, Anna Hadjihambi

Abstract readReview
In one paragraph

Review in Nature reviews. Gastroenterology & hepatology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Article
  2. Review
  3. Review
  4. Review
  5. Article
  6. Review
  7. Review
  8. Article
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Matthew Siddle *Roger Williams Institute of Liver Studies, School of Immunology & Microbial Sciences, Faculty of Life Sciences and Medicine, King's College London, Foundation for Liver Research and King's College Hospital, London, UK.
Rocío Gallego Durán *UCM Digestive Diseases, Virgen del Rocío University Hospital, Instituto de Biomedicina de Sevilla (HUVR/CSIC/US), Department of Medicine, University of Seville, Seville, Spain.
Deepika Goel *Biomedical Research Facility, Department of Life Sciences, University of Sussex, Brighton, UK.
Benjamin J RenquistSchool of Animal and Comparative Biomedical Sciences and Bio5 Institute, University of Arizona, Tucson, AZ, USA.ORCID http://orcid.org/0000-0003-1517-8226
Marie K HoltSchool of Life Sciences, University of Warwick, Coventry, UK.
Anna HadjihambiRoger Williams Institute of Liver Studies, School of Immunology & Microbial Sciences, Faculty of Life Sciences and Medicine, King's College London, Foundation for Liver Research and King's College Hospital, London, UK. a.hadjichambi@researchinliver.org.uk.ORCID http://orcid.org/0000-0001-9418-3589

Funding

Role of the hepatic GABA shunt in insulin resistance and hyperinsulinemiaR01DK132281 · UNIVERSITY OF ARIZONA · 2025 to 2025
$384k
NIDDK NIH HHS R01 DK132281
6 · The paper itself

Abstract

The liver is a metabolically flexible tissue, adapting its functions to changes in nutrient availability and physiological states. This adaptability is crucial for maintaining metabolic homeostasis and likely involves communication with the central nervous system through the liver-brain axis. The liver also receives a constant influx of nutrients, hormones and microbial metabolites from the gastrointestinal tract in a multifaceted communication network, the gut-liver-brain axis. Dysregulation of this communication can lead to hepatic encephalopathy and cognitive impairments in early-stage chronic liver disease, such as metabolic dysfunction-associated steatotic liver disease, substantially affecting patient quality of life. This Review examines key signalling pathways along the liver-brain axis: humoral signalling, including metabolites, hepatokines, toxins and inflammation, and neural pathways, focusing on afferent signalling through the common hepatic branch of the vagus nerve. We discuss how each pathway might contribute to behavioural and mood changes in chronic liver disease and the development of hepatic encephalopathy. Although the humoral effects have been studied more extensively, we propose that the afferent vagus nerve is central to liver disease-associated cognitive and behavioural complications. Finally, we highlight how new techniques and tools could advance our understanding of the gut-liver-brain communication that affects behaviour.

Indexed as

BrainLiverLiver DiseasesChronic DiseaseHepatic EncephalopathyHumansSignal TransductionVagus Nerve

Identifiers

PMID41214287
PMCPMC13034676

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.